期刊文献+

乳清酸磷酸核糖转移酶和结直肠癌化疗毒性的相关性 被引量:3

Expressions of orotate phosphoribosyltransferase in colorectal carcinoma and its correlations with toxicities of chemotherapy
下载PDF
导出
摘要 目的研究结直肠癌患者乳清酸磷酸核糖转移酶(OPRT)的表达及其同化疗毒性的相关性。方法应用逆转录-聚合酶链式反应(RT-PCR)法检测58例结直肠癌组织及癌旁正常组织OPRT的表达,同时观察患者接受FOLFOX6方案化疗的毒性,分析二者的相关性。结果结直肠癌组织OPRT的表达高于相应正常肠粘膜组织,差异具有显著性(P=0.001)。结直肠癌组织OPRT的表达状况和化疗反应无明显相关性(P>0.05)。正常组织OPRT水平和腹泻的发生呈正相关,并具有统计学意义(P=0.013)。结论结直肠癌组织OPRT的表达和结直肠患者的化疗毒性无相关;而癌旁正常组织OPRT的表达可以预测5-FU相关毒性的发生情况。 Objective To investigate the expression of orotate phosphoribosyltransferase (OPRT) in colorectal carcinoma and analyze its correlations with the toxicities of chemotherapy. Methods The expression of OPRT mRNA was detected using RT-PCR in colorectal carcinoma tissues and paired adjacent normal tissues from 58 patients receiving FOLFOX6 regimen chemotherapy. The toxicities of the chemotherapy were recorded, and the correlations between OPRT mRNA expression and the toxicities were analyzed. Results OPRT mRNA expression was significantly higher in the tumor tissues than in the corresponding normal tissues (P=0.001), but OPRT expression in the tumor tissues was not correlated with the toxicities of the chemotherapy (P〉0.05). OPRT level in the normal tissues showed a significant positive correlation with the occurrence of diarrhea in these cases (P=0.013). Conclusion OPRT expression in colorectal carcinoma tissues is not correlated with the toxicities of 5-FU-based regimen, but OPRT expression in the normal tissues can help predict the toxicities associated with 5-FU.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第8期1179-1181,1200,共4页 Journal of Southern Medical University
基金 广东省科技计划项目(2008B030301181)
关键词 结直肠癌 乳清酸磷酸核糖转移酶 5-FU FOLFOX6 毒性 colorectal carcinoma orotate phosphoribosyltransferase 5-fluor ouracil toxicit
  • 相关文献

参考文献17

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics2012 [J]. CA Cancer J Clin, 2010, 62(1): 10-29.
  • 2李连弟,饶克勤,张思维,鲁凤珠,邹小农.中国12市县1993年~1997年肿瘤发病和死亡登记资料统计分析[J].中国肿瘤,2002,11(9):497-507. 被引量:193
  • 3Maindrault-Goebel F, Louvet C, Andr6 T, et al. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR[J]. Eur J Cancer, 1999, 35(9): 1338-42.
  • 4Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin,fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J]. Engl J Med, 2004, 350(23): 2343-51.
  • 5Ducreux M, Bennouna J, Hebbar M, et al. Capecitabine plus oxaliplatin (XELOX) versus 5- plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer [J]. Int J Cancer, 2011, 128(3): 682-90.
  • 6Ichikawa W, Uetake H, Shirota Y, et al. Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine- based chemotherapy for metastatic colorectal cancer [J]. Br J Cancer, 2003, 89(8): 1486-92.
  • 7Ichikawa W, Takahashi T, Suto K, et al. Orotate phosphoribosyl- transferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen [J]. Clin Cancer Res, 2006, 12 (13): 3928-34.
  • 8Takechi T, Nakano K, Uchida J, et al. Antitumor activity and low intestinal toxicity of S-l, a new formulation of oral tegafur, in experimental tumor models in rats [J]. Cancer Chemother Pharmacol, 1997, 39(3): 205-11.
  • 9Saif MW, Syrigos KN, Katirtzoglou NA. S-l: a promising new oral fluoropyrimidine derivative [J]. Expert Opin Investig Drugs, 2009, 18(3): 335-48.
  • 10Sakamoto E, Nagase H, Kobunai T, et al. Orotate phosphoribosyl- transferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracil [J]. Biochem Biophys Res Commun, 2007, 363(1): 216-22.

共引文献192

同被引文献58

  • 1魏嘉,王立峰,刘宝瑞.5-FU相关的药物疗效及毒性预测分子研究进展[J].世界华人消化杂志,2005,13(15):1889-1893. 被引量:8
  • 2Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis [ J ]. International Journal of Cancer, 2009, 124 ( 10 ) : 2406-2415.
  • 3Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drink- ing and colorectal cancer risk: an overall and dose-response meta-analysis of published studies[J]. Annals of Oncology, 2011,22(9) : 1958-1972.
  • 4Larsson SC, Wolk A. Meat consumption and risk of colorec- tal cancer : a meta-analysis of prospective studies [ J ]. International Journal of Cancer, 2006, 119 ( 11 ) : 2657-2664.
  • 5Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorec- tal cancer: a systematic review of prospective studies [ J ]. PLoS One, 2013, 8(1) : e53916.
  • 6Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis [J]. Journal of the Na- tional Cancer Institute, 2005, 97(22) : 1679-1687.
  • 7Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physi- cal activity and survival after colorectal cancer diagnosis [ J ]. Journal of Cclinical Oncology, 2006, 24(22) : 3527-3534.
  • 8Kinzler KW, Vogelstein B. Lessons from hereditary colorec- tal cancer[J]. Cell, 1996, 87(2) : 159-170.
  • 9Zanke BW, Greenwood CMT, Rangrej J, et al. Genome- wide association scan identifies a colorectal cancer suscepti- bility locus on chromosome 8q24 [ J ]. Nature Genetics, 2007, 39(8) : 989-994.
  • 10Tomlinson I, Webb E, Carvajal-Carmona L, et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24. 21 [J]. Nature Genetics, 2007, 39(8):984-988.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部